Patidegib

Star0

DB12655InvestigationalSmall molecule

Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.

Mechanism: Pharmacologically active on Protein smoothened
Curator reviewed
Formula / weight: C₂₉H₄₈N₂O₃S · 504.77 g/mol (avg)
Also known as: Saridegib
Code names: IPI-926 · IPI-926 FREE BASE

Resolves to

Compound

UNIIJT96FPU35XCAS1037210-93-7ChEMBLCHEMBL538867PubChem25027363

Structure

InChIKeyHZLFFNCLTRVYJG-WWGOJCOQSA-NSMILESC[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](CC[C@]4(C)[C@H]3CC2=C(C)C1)NS(C)(=O)=O

Targets

Q99835SMO

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

13Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Patidegib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account